tiprankstipranks
Trending News
More News >
Cytokinetics (CYTK)
NASDAQ:CYTK
US Market
Advertisement

Cytokinetics (CYTK) Financial Statements

Compare
1,157 Followers

Cytokinetics Financial Overview

Cytokinetics's market cap is currently $6.68B. The company's EPS TTM is $-1.12; its P/E ratio is ―; Cytokinetics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-1.57. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Cytokinetics Earnings and Revenue History

Cytokinetics Debt to Assets

Cytokinetics Cash Flow

Cytokinetics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis